Kanker paru-paru sél sanés alit sareng metastasis otak sareng terapi sasaran ALK

Non-small cell lung cancer and brain metastasis Previously, non-small cell lung cancer (NSCLC) brain metastases had a poor prognosis, with a median survival time of 7 months. But tumor-specific mutations have triggered a wave of ..

Iressa Trocaine dina pengobatan kanker paru-paru sél non-leutik anu mutasi EGFR

Cancer genetic testing Cancer gene testing guides targeted therapy as the core technology for precise cancer treatment. Every cancer patient should perform cancer gene testing for himself, looking for effective targeted drugs and ..

Tés genetik nungtun pangubaran kanker paru ALK positip

Tes genetik kanker Panungtun tés gen kanker dipandu terapi anu ditargetkeun salaku téknologi inti pikeun pengobatan kanker anu tepat. Unggal pasien kanker kedah ngalakukeun tés gén kanker pikeun dirina, milarian ubar anu ditargetkeun efektif sareng c..

Radiosurgi tumor non-invasi pikeun kanker paru

maotna patali kanker di Amérika SerikatThe American Cancer Society diterbitkeun 2015 laporan statistik kanker taunan na online on January 5, 2015. Laju maot kanker di Amérika Serikat geus fallen ku 22% ti puncak na di 1991 mun ..

Tés genetik sababaraha tumor kanker paru-paru

A study published online in the Journal of the American Medical Association on May 21st showed that multiple genetic tests of lung cancer tumors can help select genetic abnormalities for targeted therapy. Compared with patients w..

Radioterapi stéotaktik pikeun kanker paru-paru anu teu tiasa dicabut operasi

Terapi radiasi awak stereotaktikStereotactic body radiation therapy (SBRT), ogé katelah stereotactic ablative radiotherapy (SABR). Kusabab aplikasina dina pertengahan 1990-an, SBRT parantos ngabédakeun dirina dina pangobatan radikal.

Pitunjuk pikeun ngagunakeun Opdivo -nivolumab pikeun penderita kanker paru sél sanés alit

Opdivo parantos didaptarkeun di Amérika Serikat pikeun pengobatan kanker paru-paru. Seueur pasien kanker henteu tiasa angkat ka luar negeri pikeun pengobatan pikeun sababaraha alesan. Konsultasi ka Opdivo kumaha cara ngagunakeunana sareng mugia tiasa ngagaleuh obat ti luar negeri..

Obat anti kanker Opdivo janten ubar PD-1 munggaran anu ngubaran kanker paru-paru

On January 13, 2015, Huanyu Dakang Médis Médis farmasi buta Squibb Company ushered dina mimiti alus di 2015. The anti kanker immunotherapy ubar nivolumab dikembangkeun ku pausahaan ieu disatujuan bulan panungtungan handapeun na dagang.

Studi kasus kanker paru-paru sareng uji klinis

1. Diagnosis sareng pengobatan munggaran kanker paru-paruPasén Lu didiagnosis adenocarcinoma paru-paru sareng metastasis titik limfa dina 26 Agustus 2005. Lobectomy kénca handap dilaksanakeun dina 22 Séptémber 2005. Carboplatin digabungkeun sareng ..

carana ngumpulan

Klasifikasi adenocarcinoma paru sareng sudut pandang operasi kanker paru-paru

1. Ruang lingkup individual reseksi parenchymal paru Kusabab 1960s, paduli ukuran tumor, lobectomy anatomis geus jadi standar pikeun pengobatan bedah kanker paru sél non-leutik. Sanajan kitu, fungsi paru o..